Cresset Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
5,445
-3,242
| -37% | -$932K | 0.01% | 627 |
|
|
2025
Q1 | $2.68M | Buy |
8,687
+108
| +1% | +$33.3K | 0.01% | 451 |
|
|
2024
Q4 | $3.03M | Sell |
8,579
-811
| -9% | -$286K | 0.01% | 435 |
|
|
2024
Q3 | $3.36M | Buy |
9,390
+458
| +5% | +$164K | 0.01% | 566 |
|
|
2024
Q2 | $2.85M | Buy |
8,932
+908
| +11% | +$289K | 0.01% | 561 |
|
|
2024
Q1 | $1.84M | Buy |
8,024
+1,112
| +16% | +$255K | 0.01% | 668 |
|
|
2023
Q4 | $1.52M | Buy |
6,912
+1,127
| +19% | +$248K | 0.01% | 691 |
|
|
2023
Q3 | $1.31M | Buy |
5,785
+731
| +14% | +$165K | 0.01% | 690 |
|
|
2023
Q2 | $1.12M | Buy |
+5,054
| New | +$1.12M | ﹤0.01% | 762 |
|
|
2022
Q1 | – | Sell |
-2,254
| Closed | -$488K | – | 1149 |
|
|
2021
Q4 | $488K | Buy |
2,254
+256
| +13% | +$55.4K | ﹤0.01% | 708 |
|
|
2021
Q3 | $368K | Buy |
1,998
+20
| +1% | +$3.68K | 0.01% | 748 |
|
|
2021
Q2 | $355K | Sell |
1,978
-1
| -0.1% | -$179 | 0.01% | 696 |
|
|
2021
Q1 | $331K | Buy |
+1,979
| New | +$331K | 0.01% | 634 |
|
|
2019
Q2 | – | Sell |
-638
| Closed | -$75K | – | 1652 |
|
|
2019
Q1 | $75K | Buy |
638
+628
| +6,280% | +$73.8K | ﹤0.01% | 655 |
|
|
2018
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1613 |
|